E
Efrem D. Mandelcorn
Researcher at University Health Network
Publications - 72
Citations - 1575
Efrem D. Mandelcorn is an academic researcher from University Health Network. The author has contributed to research in topics: Visual acuity & Vitrectomy. The author has an hindex of 14, co-authored 60 publications receiving 1159 citations. Previous affiliations of Efrem D. Mandelcorn include University of Toronto & Toronto Western Hospital.
Papers
More filters
Journal ArticleDOI
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
Dora Liu,Alexandra Ahmet,Leanne M Ward,Preetha Krishnamoorthy,Efrem D. Mandelcorn,Richard Leigh,Jacques P. Brown,Albert Cohen,Harold Kim,Harold Kim +9 more
TL;DR: This comprehensive article reviews these adverse events of systemic corticosteroid therapy and provides practical recommendations for their prevention and management based on both current literature and the clinical experience of the authors.
Journal ArticleDOI
Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection.
Vivian T. Yin,Daniel J. Weisbrod,Kenneth T. Eng,Carol Schwartz,Radha P. Kohly,Efrem D. Mandelcorn,Wai Ching Lam,Nick Daneman,Andrew E. Simor,Peter J. Kertes +9 more
TL;DR: Repeated use of topical moxifloxacin after IVT injection significantly increases antibiotic resistance of ocular surface flora, and it is recommended that routine use of prophylactic antibiotics afterIVT injection be discouraged.
Journal ArticleDOI
Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma
TL;DR: A 36-year-old woman treated with the anti PD-1 antibody Pembrolizumab for metastatic cutaneous melanoma in the first line setting achieved a complete response and then relapsed with metastases to the vitreous cavity with an associated angiographically determined retinal vasculitis, highlighting the need for immune sanctuary sites to be monitored in the presence ofPD-1 inhibition.
Journal ArticleDOI
Induction of macular detachment for the treatment of persistent or recurrent idiopathic macular holes.
TL;DR: In eyes with persistent or recurrent idiopathic macular holes after standard PPVs with internal limiting membrane peeling, repeat PPV with subretinal balanced salt solution injection to create a macular detachment may be a viable surgical treatment option.
Journal ArticleDOI
Surgical macular decompression for macular edema in retinal vein occlusion
TL;DR: Macular decompression by internal limiting membrane (ILM) peeling may reduce macular edema and hemorrhage and improve visual acuity by relieving elevated intraretinal tissue pressure and facilitating egress of blood and extracellular fluid out of inner retinal layers into the vitrectomized vitreous cavity.